Search Within

David H Abramson

  1. "Sarcoma Service"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (8)
  2. Pediatrics, Department of (8)
  3. Sarcoma Service (8)
  4. Solid Tumor Oncology Division (8)
  5. Surgery (8)
  6. GSK Faculty (7)

More Groups

People
  1. Paul Chapman (5)
  2. Mark Dickson (4)
  3. Alexander Shoushtari (3)
  4. Brian Marr (3)
  5. Gary Schwartz (3)
  6. Jasmine Francis (3)

More People

Years
  1. 2024 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2017 (2)
  5. 2014 (1)
  6. 2012 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Clinical Cancer Research (1)
  3. JAMA - Journal of the American Medical Association (1)
  4. Journal of Cancer Research and Clinical Oncology (1)
  5. Journal of Thoracic Oncology (1)
  6. Ocular Oncology and Pathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)
  4. Elsevier Inc. (1)
  5. Elsevier Science, Inc. (1)
  6. Karger (1)

More Publishers

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of Li-Fraumeni and germline retinoblastoma mutations on leiomyosarcoma initiation, outcomes, and genetic testing recommendations
    Journal Article

    Dermawan, J. K.; Abramson, D. H.; Chiang, S.; Hensley, M. L.; Tap, W. D.; Movva, S.; Maki, R. G.; Mandelker, D.; Antonescu, C. R.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • MEK inhibitor-associated central retinal vein occlusion associated with hyperhomocysteinemia and MTHFR variants
    Journal Article

    Francis, J. H.; Diamond, E. L.; Chi, P.; Jaben, K.; Hyman, D. M.; Abramson, D. H.
    Ocular Oncology and Pathology (2020)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and morphologic characteristics of MEK inhibitor - Associated retinopathy: Differences from central serous chorioretinopathy
    Journal Article

    Francis, J. H.; Habib, L. A.; Abramson, D. H.; Yannuzzi, L. A.; Heinemann, M.; Gounder, M. M.; Grisham, R. N.; Postow, M. A.; Shoushtari, A. N.; Chi, P.; more...
    Ophthalmology (2017)

    Fulltext@MSK | Save
  • Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma
    Journal Article

    Atkinson, T. M.; Hay, J. L.; Shoushtari, A.; Li, Y.; Paucar, D. J.; Smith, S. C.; Kudchadkar, R. R.; Doyle, A.; Sosman, J. A.; Quevedo, J. F.; more...
    Journal of Cancer Research and Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: A randomized clinical trial
    Journal Article

    Carvajal, R. D.; Sosman, J. A.; Quevedo, J. F.; Milhem, M. M.; Joshua, A. M.; Kudchadkar, R. R.; Linette, G. P.; Gajewski, T. F.; Lutzky, J.; Lawson, D. H.; more...
    JAMA - Journal of the American Medical Association (2014)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in the treatment of uveal melanoma: The Memorial Sloan-Kettering Cancer Center experience
    Meeting Abstract

    Khan, S. A.; Callahan, M.; Postow, M. A.; Chapman, P. B.; Schwartz, G. K.; Dickson, M. A.; D'Angelo, S. P.; Luke, J. J.; Bluth, M. J.; Roman, R. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save